ARCHIVES

FDA Approves BMS’s Yervoy For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

PET Response Can Predict Increased Survival In Patients

April 27, 2012

In Brief: THOMAS BURKE Stepped Down As Executive Vice President And Physician-In-Chief at MD Anderson Cancer Center To Accept The New Position Of Executive Vice President of the MD Anderson Cancer Network

December 13, 2013

ONS Continue Growth, Associate Category Defeated Again

May 15, 1987